Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Vitamin D concentrations were low in the Bhadada cohort (median: 55.0 nmol/L [IQR: 18.7 to 85.5]) and in the majority of the case‐report group with available data (median: 20.0 nmol/L [IQR: 17.0 to 30.0]), with no statistically significant difference (p = 0.301).
Source: 3. Results. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Biochemical Predictors and Clinical Characteristics for the Development of Cytopenia and Bone Marrow Involvement Among Patients With Primary Hyperparathyroidism
Study design awaiting verification · International Journal of Endocrinology · 2026
Original publication title
Biochemical Predictors and Clinical Characteristics for the Development of Cytopenia and Bone Marrow Involvement Among Patients With Primary Hyperparathyroidism
Copyright © 2026 Omer Abdelfadiel et al. International Journal of Endocrinology published by John Wiley & Sons Ltd.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
The clinical features associated with primary hyperparathyroidism (PHPT) giving rise to bone marrow fibrosis are poorly documented. We hypothesised that the severity of PHPT may contribute to the development of this complication.
Source: BackgroundAbstract: What methods does the paper describe?
We identified two clinical cases managed within our clinical service and reviewed case reports and cohort studies using search terms, inter alia, ‘primary hyperparathyroidism,’ ‘pancytopenia,’ ‘myelofibrosis’ and ‘bone marrow fibrosis,’ utilising PubMed, Google Scholar, Microsoft Academic Search and Web of Science. We excluded patients with chronic renal failure and/or secondary hyperparathyroidism. Studies lacking a histological assessment of bone marrow were also excluded.
Source: MethodsAbstract: Results
We identified a total of 41 reports that satisfied our search criteria, comprising individual cases and three previously reported cohorts. Of these, 27 cases were excluded as they had secondary hyperparathyroidism from renal failure, or because an alternative aetiology for bone marrow fibrosis, such as toxin exposure, was identified. In addition, one large cohort of patients with PHPT and cytopenia was excluded due to the absence of a bone marrow biopsy and missing key biochemical and skeletal data. The included reports consisted of 11 individual cases of bone marrow fibrosis associated with PHPT, along with 2 small cohorts of 17 and 8 patients, respectively.
Common clinical features across the 11 case reports included markedly elevated parathyroid hormone (PTH) levels (mean ± SD: 130 ± 95.8 pmol/L; normal range: 1.1 to 6.9 pmol/L), low serum 25‐hydroxyvitamin D (median [IQR]: 20.0 [17.0 to 30.0] nmol/L; normal range: 75 to 150 nmol/L) and significantly elevated alkaline phosphatase (ALP) (median [IQR]: 361 [293 to 1372]) U/L; normal range: 30 to 120 U/L). Bone marrow fibrosis in this instance is reversible following excision of the culprit parathyroid lesion.
Source: ResultsAbstract: Conclusion
Bone marrow fibrosis associated with PHPT occurs predominantly in the setting of severe biochemical disease, characterised by markedly elevated PTH and ALP levels and may present with variable patterns of cytopenia. While symptom duration varies widely, disease severity rather than chronicity appears to be the principal determinant for bone marrow involvement. Haematological abnormalities are reversible following parathyroidectomy, highlighting the importance of timely diagnosis and intervention.
Source: ConclusionAuthors’ abstract
Background
The clinical features associated with primary hyperparathyroidism (PHPT) giving rise to bone marrow fibrosis are poorly documented. We hypothesised that the severity of PHPT may contribute to the development of this complication.
Methods
We identified two clinical cases managed within our clinical service and reviewed case reports and cohort studies using search terms, inter alia, ‘primary hyperparathyroidism,’ ‘pancytopenia,’ ‘myelofibrosis’ and ‘bone marrow fibrosis,’ utilising PubMed, Google Scholar, Microsoft Academic Search and Web of Science. We excluded patients with chronic renal failure and/or secondary hyperparathyroidism. Studies lacking a histological assessment of bone marrow were also excluded.
Results
We identified a total of 41 reports that satisfied our search criteria, comprising individual cases and three previously reported cohorts. Of these, 27 cases were excluded as they had secondary hyperparathyroidism from renal failure, or because an alternative aetiology for bone marrow fibrosis, such as toxin exposure, was identified. In addition, one large cohort of patients with PHPT and cytopenia was excluded due to the absence of a bone marrow biopsy and missing key biochemical and skeletal data. The included reports consisted of 11 individual cases of bone marrow fibrosis associated with PHPT, along with 2 small cohorts of 17 and 8 patients, respectively.
Common clinical features across the 11 case reports included markedly elevated parathyroid hormone (PTH) levels (mean ± SD: 130 ± 95.8 pmol/L; normal range: 1.1 to 6.9 pmol/L), low serum 25‐hydroxyvitamin D (median [IQR]: 20.0 [17.0 to 30.0] nmol/L; normal range: 75 to 150 nmol/L) and significantly elevated alkaline phosphatase (ALP) (median [IQR]: 361 [293 to 1372]) U/L; normal range: 30 to 120 U/L). Bone marrow fibrosis in this instance is reversible following excision of the culprit parathyroid lesion.
Conclusion
Bone marrow fibrosis associated with PHPT occurs predominantly in the setting of severe biochemical disease, characterised by markedly elevated PTH and ALP levels and may present with variable patterns of cytopenia. While symptom duration varies widely, disease severity rather than chronicity appears to be the principal determinant for bone marrow involvement. Haematological abnormalities are reversible following parathyroidectomy, highlighting the importance of timely diagnosis and intervention.
Publication and source details
Original title: Biochemical Predictors and Clinical Characteristics for the Development of Cytopenia and Bone Marrow Involvement Among Patients With Primary Hyperparathyroidism
Omer Abdelfadiel; Mohamed Abdalla; Ian Louis Ross
International Journal of Endocrinology · 2026
Copyright © 2026 Omer Abdelfadiel et al. International Journal of Endocrinology published by John Wiley & Sons Ltd.2026https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the https://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T22:02:37.857241+00:00
DOI: 10.1155/ije/4158433 · PMC13403217